Personalis at Liquid Biopsy for Precision Oncology Summit US: 10th-11th February 2022 NeXT Personal: Next Generation MRD Testing for Solid Tumors February 10: 12:30-1:00 PM PST Dan Norton, MBA Associate Director, Product Management Personalis, Inc. The ability to monitor and predict molecular recurrence [...]
2021 SITC Online Sponsored Symposium | November 12, 2021 Leveraging comprehensive genomic data for diagnostic capabilities and composite biomarker discovery in immunotherapy Erin Newburn, MS, PhD Director, Field Application Scientist Personalis, Inc. To enable the identification of composite biomarkers that combine tumor- and immune-related information [...]
2021 NeXT Level Biomarkers Symposium: Welcome Message Richard Chen, MD, MS Chief Scientific Officer Personalis, Inc.
2021 AACR Personalis Product Demo Advancing Biomarker Discovery: Enabling improved tumor immunogenomics through a comprehensive approach Travis Yates, PhD Field Applications Scientist This presentation will cover: Predicting patient response to immunotherapies requires a robust and comprehensive approach to tumor immunogenomics. By combining highly [...]
Biomarker Discovery Solutions for Lymphoma & Multiple Myeloma Comprehensive Characterization of Genetic Events With Combinatorial DNA and RNA Profiling Travis Yates, PhD Field Application Scientist Lymphoma and multiple myeloma account for more than 65 percent of newly diagnosed hematological cancer cases. The genetic landscape of these [...]
Introduction to Liquid Biopsies Maik M. Pruess, PhD Sr. Field Application Scientist The liquid biopsy is a relatively new concept that has gained traction over the last several years. Circulating tumor DNA (ctDNA) fragments are released by tumor cells into the blood, and contain [...]
Current Challenges in Liquid Biopsies Maik M. Pruess, PhD Sr. Field Application Scientist The liquid biopsy has the potential to change cancer research and clinical care through a variety of applications, from early detection and monitoring, to detection of drug resistance and minimal residual [...]
2020 EACR Liquid Biopsies Sponsored Symposia NeXT Liquid Biopsy, A High Performance, Exome-Wide Liquid Biopsy Assay to Study Tumor Dynamics Erin Newburn, PhD Associate Director, Field Applications Scientist Dan Norton, MBA Sr. Product Manager NeXT Liquid Biopsy™, a first-of-its-kind, high-performance exome-wide [...]
2020 Breast Cancer Summit Presentation Enabling multidimensional tumor immunogenomics for advancing biomarker discovery Christelle Johnson, PhD Senior Field Application Scientist Enabling multidimensional tumor immunogenomics for advancing biomarker discovery Insight into the complex and dynamic interactions between the tumor and immune cells of the microenvironment is essential for cancer immunotherapy translational studies Purpose built [...]
2020 EACR Virtual Congress: Industry Symposium Enabling Composite Biomarker Discovery for Precision Cancer Therapy with an Enhanced Exome and Transcriptome Platform Erin Newburn, MS, PhD Director, Field Application Scientist Enabling Composite Biomarker Discovery for Precision Cancer Therapy with an Enhanced Exome and Transcriptome Platform In this presentation, we’ll provide an overview of the [...]
